Both in Pharmaceuticals
Theriva Biologics vs GT Biopharma
Over the past year TOVX returned −41.7% and GTBP returned −69.3%; their daily moves had a correlation of 0.06.
TOVX −41.7% GTBP −69.3%Growth of $1, one year, split-adjusted
| Metric | TOVX | GTBP |
|---|---|---|
| Price | $0.1911 | $5.33 |
| Market cap | $8.8M | $9.6M |
| Today | −2.50% | −2.38% |
| 1 month | −13.4% | −22.6% |
| 6 months | −46.0% | −23.8% |
| Year to date | −9.2% | −72.8% |
| 1 year | −44.1% | −70.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 29.2× | — |
| Net cash | $9.7M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 47.7% | 958.1% |
| Short % of float | 3.7% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).